The effect of topical pimecrolimus on inflammatory infiltrate in vulvar lichen sclerosus.
暂无分享,去创建一个
S. Kauppila | R. Nissi | V. Kotila | P. Väre | E. Knuuti | Pia Vittaniemi
[1] T. Luger,et al. Potential New Indications of Topical Calcineurin Inhibitors , 2007, Dermatology.
[2] J. Risteli,et al. Pimecrolimus Cream 1% in the Treatment of Lichen Sclerosus , 2006, Gynecologic and Obstetric Investigation.
[3] P. Millard,et al. Cytokine alterations in lichen sclerosus: an immunohistochemical study , 2006, The British journal of dermatology.
[4] M. Steinhoff,et al. Pimecrolimus – an anti‐inflammatory drug targeting the skin , 2004, Experimental dermatology.
[5] J. McGrath,et al. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus , 2003, The Lancet.
[6] C. Borror. Nonparametric Statistical Methods, 2nd, Ed. , 2001 .
[7] M. Mihm,et al. Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesions, and etiology of 141 cases. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[8] D. Wolfe,et al. Nonparametric Statistical Methods. , 1974 .